Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (41)
  • 2025 (44)
  • 2024 (32)
  • 2023 (22)
  • 2022 (32)
  • 2021 (57)
  • 2020 (48)
  • 2019 (46)
  • 2018 (73)
  • 2017 (63)
  • 2016 (51)
  • 2015 (41)
  • 2014 (53)
  • 2013 (66)
  • 2012 (16)
  • 2011 (59)

Subject

  • Drug Trafficking (88)
  • Synthetic drugs (36)
  • Prescription Drugs (34)
  • Take Back Day (32)
  • Arrests/Convictions - Major (31)
  • Outreach/Drug Prevention (27)
  • Fake Pills (24)
  • Fentanyl Awareness (24)
  • Overdose (24)
  • Guns/Weapons (17)
  • Public and Media Affairs - also see Congressional Affairs (17)
  • Seizures (Drugs/Property) (17)
  • Diversion Division (15)
  • Major Law Enforcement Operation (15)
  • Fentanyl Free America (14)
  • One Pill Can Kill (14)
  • Pharmaceuticals/Pharmacists/Physicians (14)
  • Congressional Affairs (12)
  • Money Laundering (12)
  • Press Conferences (12)
  • Prevention/Education - DEA websites GSAD, JTT etc (9)
  • Red Ribbon (9)
  • International/Foreign Operations (7)
  • Narcoterrorism (7)
  • OCDETF/Task Force (7)
  • Extraditions (5)
  • Gangs (5)
  • HIDTA (5)
  • Cartel (4)
  • Guilty Plea (4)
  • Intergovernmental Affairs (4)
  • Campaigns (3)
  • Counterfeit Pills (3)
  • Critical Incident (3)
  • Other (3)
  • Task Forces/Task Force Officers (3)
  • Terrorism (3)
  • Scam Calls (2)
  • Dark Web- Internet Trafficking (1)
  • Intelligence Division - Intelligence Products (1)
  • Museum and Visitors Center (1)

Drug Name

  • Fentanyl (81)
  • Methamphetamine (50)
  • Cocaine (39)
  • Heroin (17)
  • Marijuana (Cannabis) (8)
  • Oxycodone (6)
  • Synthetic Opioids (6)
  • Ketamine (5)
  • Opioids (5)
  • Ecstasy/MDMA (2)
  • Marijuana Concentrates (2)
  • Benzodiazepines (1)
  • GHB (1)
  • Psilocybin (1)

Field Division

  • Atlanta (802)
  • Caribe (96)
  • Caribe (1)
  • Chicago (651)
  • Dallas (330)
  • Detroit (368)
  • El Paso (360)
  • Houston (926)
  • Los Angeles (316)
  • Louisville (96)
  • Miami (893)
  • New England (2470)
  • New Jersey (499)
  • New Orleans (514)
  • New York (1550)
  • Omaha (157)
  • Philadelphia (140)
  • Phoenix (278)
  • Rocky Mountain (169)
  • San Diego (251)
  • San Francisco (864)
  • Seattle (844)
  • Sede (433)
  • St. Louis (821)
  • Washington, DC (621)
Clear All Results
744 Results - Showing 391 to 400
PRESS RELEASE

DEA Announces Step To Increase Opioid Addiction Treatment

WASHINGTON - The United States Drug Enforcement Administration today announced a deregulatory measure that will make it easier for residents of underserved areas to receive treatment for opioid addiction. As published today in the Federal Register, nurse practitioners and physician assistants can now become DATA-Waived qualifying practitioners, which gives them...
PRESS RELEASE

Monrovia Man Found Guilty In ‘hawala’ Scheme To Move Money For International Drug Trafficking Organizations

LOS ANGELES - A federal jury has convicted a Monrovia man for his role in an international money laundering organization that conspired to move millions of dollars in proceeds for narcotics traffickers that included the Sinaloa Cartel. The conviction stems from an investigation led by the Drug Enforcement Administration’s LA...
PRESS RELEASE

DEA Investigation Unravels Drug Trafficking And Corruption By Honduran Congressman

WASHINGTON - A member of the Honduran National Congress faces U.S. charges for drug trafficking, weapons and conspiracy thanks to a DEA-led international drug investigation, federal law enforcement officials announced today. Honduran Congressman Fredy Renan Najera Montoya has been charged in Manhattan federal court with conspiring to import cocaine into...
PRESS RELEASE

DEA Speeds Up Application Process For Research On Schedule I Drugs

WASHINGTON - The Drug Enforcement Administration is streamlining the application process for researchers who study or wish to study Schedule I substances not currently approved for medical use. Schedule I drugs are defined as drugs, substances, or chemicals with no accepted medical use and a high potential for abuse, such...
PRESS RELEASE

China Announces Scheduling Controls On Two Fentanyl Precursor Chemicals

WASHINGTON - China’s Ministry of Public Security last week announced scheduling controls on two fentanyl precursor chemicals - NPP and 4ANPP, substances that can be used to make illicit drugs. The scheduling controls will take effect on February 1, 2018 and is the result of the ongoing collaboration between the...
PRESS RELEASE

Nephews Of Venezuela First Lady Each Sentenced To 18 Years In Prison For Conspiring To Import Cocaine Into The United States

WASHINGTON - Joon H. Kim, the Acting United States Attorney for the Southern District of New York, and Raymond Donovan, the Special Agent-in-Charge of the Drug Enforcement Administration’s Special Operations Division, announced today that Efrain Antonio Campo (“Campo Flores”) and Franqui Francisco Flores De (“Flores De Freitas”) were each sentenced...
PRESS RELEASE

16 People Linked To San Fernando Valley-based Narcotics Delivery Service Indicted By Federal Grand Jury

LOS ANGELES - Agents with the Drug Enforcement Administration and local law enforcement authorities today took into custody seven defendants linked to a drug-distribution ring that operated out of Van Nuys and used a fleet of cars and a staff of drivers to make rapid deliveries - primarily of heroin...
PRESS RELEASE

Nevada Cardiologist Arrested For Unlawful Distribution Of Prescription Opioids And Health Care Fraud

RENO, Nev. - An Elko, Nevada cardiologist was arrested today on 39-charges of unlawful distribution of prescription opioids and Medicare and Medicaid fraud, announced Attorney General Jeff Sessions, Acting U.S. Attorney Steven W. Myhre for the District of Nevada, Special Agent in Charge Aaron C. Rouse for the FBI’s Las...
PRESS RELEASE

DEA Large-scale Operation Targets 26 Pharmacies In Three States In Attack Against Illicit Opioid Abuse And Trafficking

WASHINGTON - The Drug Enforcement Administration’s Los Angeles Field Division today announced Operation Faux Pharmacy, a multi-pronged initiative aimed at attacking the opioid epidemic by targeting rogue pharmacies throughout southern California, Hawaii and Nevada. DEA investigations over the last year identified as many as 26 pharmacies in these areas that...
PRESS RELEASE

Attorney General Sessions And Acting DEA Administrator Patterson Announce New Tools To Address Opioid Crisis

WASHINGTON - Continuing to follow President Trump’s strong leadership on combatting the deadly opioid crisis, Attorney General Sessions today announced new resources and stepped up efforts to address the drug and opioid crisis. Joined by Acting DEA Administrator Robert Patterson, Attorney General Sessions announced the following efforts during a press...

Paginación

  • Primera página «
  • Anterior
  • Página 36
  • Página 37
  • Página 38
  • Página 39
  • Current page 40
  • Página 41
  • Página 42
  • Página 43
  • Página 44
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster